Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...
The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Medical Device Network on MSN
Medtronic’s OmniaSecure defib lead nets another FDA approval
OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.
The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.
Please provide your email address to receive an email when new articles are posted on . Left bundle branch pacing was achieved for the first time via leadless pacemaker. Implantation failure rate was ...
Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...
World’s First Leadless Left Bundle Branch Area Pacing Implant Utilizing EBR Systems’ WiSE CRT System
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that Professor Pascal Defaye, Head of Rhythmology ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results